BSECompany Update2d ago · 12 Oct 2026, 06:24 pm
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for the sale of a business unit of the Company
Bajaj Healthcare Ltd · 539872
✦ AI SummaryDivestiture
Bajaj Healthcare Ltd has disclosed the sale of a business unit to Spa Vet Private Limited and Indosol Pure Technologies Private Limited for Rs. 14.67 Crores. The transaction does not involve related parties and the trading window remains closed for designated persons.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bajaj Healthcare Ltd - 539872 - Announcement Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Attachments (1)
📄pdf
Download →
de52757e-c0ce-4a92-9e60-52dc2e20b817.pdf
View document text
Ref: BHL/ STEX 41/ 2026-27
Date: October 12, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza,
Dalal Street Bandra Kurla Complex Bandra (East)
Mumbai – 400 001 Mumbai-400051
Scrip Code: 539872 Symbol: BAJAJHCARE
Dear Sir/Madam,
Subject: Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations
2015, this is to inform you that the Company has executed a Deed of Assignment with Spa Vet Private
Limited and Indosol Pure Technologies Private Limited for the sale of an undertaking of the Company
situated at Plot No. D-2/CH/42 & D-2/CH/43 Dahej Industrial Area, GIDC, Bharuch, Gujarat.
We further confirm that none of the promoter/ promoter group/ group companies have any interest in the
aforesaid buyers and the transaction does not fall within the purview of related party transactions.
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended & as per
the Company’s code of Internal Procedures and Conduct for Regulating, Monitoring & Reporting of trading
in securities, the Trading window for dealing in securities of the Bajaj Healthcare Limited shall continue to
remain closed for all Designated Persons including their immediate relatives in terms of our earlier
disclosure dated September 23, 2026.
The brief details, in accordance with the SEBI Listing Regulations read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as “Annexure-I”.
You are requested to take the same on record.
Thanking You,
For and on behalf of Bajaj Healthcare Limited
Monica Tanwar
Company Secretary & Compliance Officer
Encl: as above
BAJAJ HEALTHCARE LIMITED
Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604
Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com
CIN No. L99999MH1993PLC072892
Annexure-I
Details required under the Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Amount
a) The amount and percentage of the turnover or revenue or The undertaking was not
income and net worth contributed by such unit or division or operational during the last financial
undertaking or subsidiary or associate company of the year, therefore turnover or revenue
listed entity during the last financial year contribution is Nil.
b) Date on which the agreement for sale has been entered into October 12, 2026
c) The expected date of completion of sale/disposal The transaction is expected to be
completed upon fulfillment of
conditions as mentioned under the
Deed of Assignment.
d) Consideration received from such sale/disposal The consideration for the
transaction is Rs. 14.67 Crores
(approx.).
e) Brief details of buyers and whether any of the buyers belong The buyers are Spa Vet Private
to the promoter/ promoter group/group companies. If yes, Limited and Indosol Pure
details thereof Technologies Private Limited.
Neither of the buyers belongs to
the Promoter/ Promoter Group/
Group Companies of the
Company.
f) Whether the transaction would fall within related party No. The transaction does not fall
transactions? If yes, whether the same is done at “arm’s within the purview of related party
length” transactions.
g) Whether the sale, lease or disposal of the undertaking is The Company obtained prior
outside Scheme of Arrangement? If yes, details of the same approval of its Shareholders on
including compliance with regulation 37A of LODR August 05, 2023 vide Postal Ballot
Regulations. Notice dated June 28, 2023 and
has complied with Regulation 37A
of SEBI Listing Regulations.
h) Additionally, in case of a slump sale, indicative disclosures Not Applicable
provided for amalgamation/merger, shall be disclosed by
the listed entity with respect to such slump sale.
BAJAJ HEALTHCARE LIMITED
Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604
Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com
CIN No. L99999MH1993PLC072892